Amneal Pharmaceuticals (AMRX) P/B ratio

P/B ratio · fiscal 2023
54.0×

The P/B ratio of Amneal Pharmaceuticals (AMRX) was 54.0× at the end of fiscal 2023 (December 31, 2023). That is 5269.7% higher than the 1.0× of fiscal 2022. Figures as of 18 Nov 2026, 07:08 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio, fiscal 2023
54.0×
Change on fiscal 2022
+5269.7%
Highest on record
54.0×fiscal 2023
Lowest on record
1.0×fiscal 2022
Fiscal years on record
62018–2023

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Amneal Pharmaceuticals P/B ratio, in more detail

Across the 6 fiscal year-ends on record (2018–2023), the highest was 54.0× in fiscal 2023 and the lowest 1.0× in fiscal 2022.

History · 6 fiscal years

P/B ratio at each fiscal year-end

Amneal Pharmaceuticals P/B ratio, year by year

Amneal Pharmaceuticals (AMRX) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
2025——$12.60-$0.22
2024——$7.92-$0.35
202354.0× 5,269.7% up$6.07$0.11
20221.0× 50.1% down$1.99$1.98
20212.0× 10.1% down$4.79$2.37
20202.2× 18.2% down$4.57$2.04
20192.7× 19.5% down$4.82$1.76
20183.4×—$13.53$3.97

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

P/B ratio at health care companies of similar size

P/B ratio of Amneal Pharmaceuticals and comparable companies
CompanyP/B ratio
Caris Life Sciences CAI9.9×
Immunovant IMVT8.1×

Today's market value divided by shareholders' equity at the latest fiscal year-end. A company whose statements are in another currency than its shares is left out.

More on AMRX

Amneal Pharmaceuticals, figure by figure

Amneal Pharmaceuticals (AMRX) overview: price, valuation and scorecardAll health care companies by market value

Amneal Pharmaceuticals P/B ratio: questions and answers

What is Amneal Pharmaceuticals's P/B ratio?

The P/B ratio of Amneal Pharmaceuticals (AMRX) was 54.0× at the end of fiscal 2023 (December 31, 2023). That is 5269.7% higher than the 1.0× of fiscal 2022.

What are the highest and lowest P/B ratio figures on record for Amneal Pharmaceuticals?

Across the 6 fiscal year-ends on record (2018–2023), the highest was 54.0× in fiscal 2023 and the lowest 1.0× in fiscal 2022.

How is Amneal Pharmaceuticals's P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amneal Pharmaceuticals (AMRX) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/AMRX/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.